Acadia Pharmaceuticals Announces Outcome of FDA Advisory Committee for NUPLAZID® (pimavanserin) for the Treatment of Alzheimer’s Disease Psychosis

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the outcome of the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) meeting for pimavanserin for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP). The PDAC voted 9 to 3 that the evidence presented does not support a conclusion … [Read more…]

Anaergia Announces Results of Voting at Annual Meeting of Shareholders

BURLINGTON, Ontario–(BUSINESS WIRE)–Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) announced today the results of voting at its annual meeting of shareholders held on June 17, 2022 (the “Meeting”). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders … [Read more…]

Healthcare Services Group, Inc. Announces Settlement of Shareholder Derivative Lawsuits

BENSALEM, Pa.–(BUSINESS WIRE)–Healthcare Services Group, Inc. (NASDAQ:HCSG) (the “Company”) has agreed to settle (the “Settlement”) the shareholder derivative actions entitled McCollum v. Wahl, et al., No. 2:20-cv-03426 (E.D. Pa.) and Batan, et al. v. Wahl, et al., No. 2:21-cv-02810 (E.D. Pa.), which had been pending in the United States District Court for the Eastern District … [Read more…]

Owlet to Participate in the 7th Annual Cowen FutureHealth Conference

LEHI, Utah–(BUSINESS WIRE)–Owlet, Inc. (NYSE: OWLT) (“Owlet” or the “Company”) today announced that it will participate in the 7th Annual Cowen FutureHealth Conference, which takes place virtually on June 22-23, 2022. Kurt Workman, Owlet’s Co-Founder and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, will engage in a fireside chat at the conference on … [Read more…]

Physicians Denounce Plan in U.S. Senate to Roll Back Cruelty-Free Cosmetics Laws

FDA Safety and Landmark Advancements Act (FDASLA) would preempt progress of 8 state cosmetics laws WASHINGTON–(BUSINESS WIRE)–If passed by the U.S. Senate, a hazardous provision included in S.4348, the Food and Drug Administration Safety and Landmark Advancements Act (FDASLA), will have a sweeping and devastating impact for animals protected by laws in eight states that … [Read more…]

Simplify Healthcare Ranks No. 15 on the Crain’s 2022 Fast 50

AURORA, Ill.–(BUSINESS WIRE)–Simplify Healthcare, one of the leading Digital Healthcare Platform providers for Payers, TPAs, and ASOs, ranks No. 15 on the “Crain’s 2022 Fast 50”. The annual Crain’s Fast 50 list showcases 50 of the Chicago-area’s fastest-growing companies, ranked by percentage revenue growth from 2016 through 2021. The full list of winners can be … [Read more…]

END THE SILENCE, Early Detection Matters for Men

Men’s Health Week Closes, Awareness Continues for the Remainder of June NORFOLK, Va.–(BUSINESS WIRE)–The official Men’s Health Week of 2022 comes to a close on June 19, but UHSM Health Share, a faith-based healthcare nonprofit, and additional nonprofit organizations, Men’s Health Network and Healthy Men, Inc., continue to share support for preventative healthcare solutions for … [Read more…]

Global Neutropenia Market (2022 to 2027) – Robust Drug Pipeline for Neutropenia Treatment Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Neutropenia Market (2022-2027) by Treatment, Distribution Channel, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Neutropenia Market is estimated to be USD 4.02 Bn in 2022 and is projected to reach USD 5.43 Bn by 2027, growing at a CAGR … [Read more…]

Global RNA Therapeutics Market Trends, Growth Drivers, and Growth Opportunities 2021-2022 & 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global RNA Therapeutics Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. This research service provides an overview of the global RNA therapeutics industry from 2021 to 2027, including emerging trends, growth drivers, and growth opportunities. Scientific advancements in nucleic acid-based therapies have significantly impacted the global biopharmaceutical industry. The ribonucleic acid (RNA) … [Read more…]